Literature DB >> 7548076

Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2.

P Ancian1, G Lambeau, M Lazdunski.   

Abstract

M-type (180 kDa) receptors for secretory phospholipases A2 (sPLA2s) are thought to mediate some of the physiological effects of group I sPLA2, including smooth muscle contraction and cell proliferation. The M-type sPLA2 receptor is a large glycoprotein composed of several distinct extracellular domains which belongs to the C-type lectin superfamily. This receptor binds with high affinity both pancreatic group I and inflammatory group II sPLA2s as well as various sPLA2s purified from snake venoms. This paper shows that the rabbit M-type sPLA2 receptor is a multifunctional protein which is able to promote cell adhesion on type I and IV collagens most probably via its N-terminal fibronectin-like type II domain. It also shows that binding of sPLA2s to a recombinant soluble form of this receptor is associated with a noncompetitive inhibition of phospholipase A2 activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548076     DOI: 10.1021/bi00040a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  A nutrient-regulated, dual localization phospholipase A(2) in the symbiotic fungus Tuber borchii.

Authors:  E Soragni; A Bolchi; R Balestrini; C Gambaretto; R Percudani; P Bonfante; S Ottonello
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

2.  Collagen binding by the mannose receptor mediated through the fibronectin type II domain.

Authors:  Catherine E Napper; Kurt Drickamer; Maureen E Taylor
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

3.  Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.

Authors:  Henrik J Jürgensen; Kristina Johansson; Daniel H Madsen; Astrid Porse; Maria C Melander; Kristine R Sørensen; Christoffer Nielsen; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

4.  The non-phagocytic route of collagen uptake: a distinct degradation pathway.

Authors:  Daniel H Madsen; Signe Ingvarsen; Henrik J Jürgensen; Maria C Melander; Lars Kjøller; Amanda Moyer; Christian Honoré; Charlotte A Madsen; Peter Garred; Sven Burgdorf; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

5.  Absence of inflammatory conditions in human varicose saphenous veins.

Authors:  Ingrid Gomez; Chabha Benyahia; Julien Le Dall; Christine Payré; Liliane Louedec; Guy Leséche; Gérard Lambeau; Dan Longrois; Xavier Norel
Journal:  Inflamm Res       Date:  2012-12-13       Impact factor: 4.575

Review 6.  Immunopathogenesis of membranous nephropathy: an update.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

7.  Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2.

Authors:  Lauren B Jensen; Nancy K Burgess; Denise D Gonda; Emily Spencer; Heather A Wilson-Ashworth; Erin Driscoll; Mai P Vu; Jeremy L Fairbourn; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

8.  Three-dimensional interplay among the ligand-binding domains of the urokinase-plasminogen-activator-receptor-associated protein, Endo180.

Authors:  Angel Rivera-Calzada; David Robertson; John R MacFadyen; Jasminka Boskovic; Clare M Isacke; Oscar Llorca
Journal:  EMBO Rep       Date:  2003-07-04       Impact factor: 8.807

9.  Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.

Authors:  Rob C Oslund; Nathan Cermak; Michael H Gelb
Journal:  J Med Chem       Date:  2008-07-08       Impact factor: 7.446

Review 10.  The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease.

Authors:  Ewa Pniewska; Rafal Pawliczak
Journal:  Mediators Inflamm       Date:  2013-05-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.